Log in

Alector Stock Price, News & Analysis (NASDAQ:ALEC)

$16.00
+0.99 (+6.60 %)
(As of 10/23/2019 06:18 AM ET)
Today's Range
$15.00
Now: $16.00
$16.09
50-Day Range
$14.07
MA: $16.30
$19.92
52-Week Range
$13.64
Now: $16.00
$27.00
Volume319,888 shs
Average Volume266,184 shs
Market Capitalization$1.10 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Alector, Inc., a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease. The company's preclinical stage products comprise AL101 for the treatment of multiple neurodegenerative disorders; and AL003 for the treatment of Alzheimer's disease. It also has 10 programs under research and development stage. The company was founded in 2013 and is headquartered in South San Francisco, California.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALEC
CUSIPN/A
CIKN/A
Phone415-231-5660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.51 million

Profitability

Miscellaneous

Employees91
Market Cap$1.10 billion
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable

Receive ALEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter.


Alector (NASDAQ:ALEC) Frequently Asked Questions

What is Alector's stock symbol?

Alector trades on the NASDAQ under the ticker symbol "ALEC."

How were Alector's earnings last quarter?

Alector Inc (NASDAQ:ALEC) posted its quarterly earnings results on Monday, August, 12th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.03. The firm earned $6.92 million during the quarter. View Alector's Earnings History.

When is Alector's next earnings date?

Alector is scheduled to release their next quarterly earnings announcement on Monday, November 11th 2019. View Earnings Estimates for Alector.

What price target have analysts set for ALEC?

6 equities research analysts have issued 1 year price targets for Alector's stock. Their forecasts range from $26.00 to $27.00. On average, they anticipate Alector's share price to reach $26.67 in the next twelve months. This suggests a possible upside of 66.7% from the stock's current price. View Analyst Price Targets for Alector.

What is the consensus analysts' recommendation for Alector?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alector.

Has Alector been receiving favorable news coverage?

Media coverage about ALEC stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Alector earned a news impact score of 2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Alector.

Are investors shorting Alector?

Alector saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 5,530,000 shares, an increase of 34.5% from the August 30th total of 4,110,000 shares. Based on an average daily trading volume, of 378,900 shares, the short-interest ratio is currently 14.6 days. Approximately 13.8% of the shares of the stock are short sold. View Alector's Current Options Chain.

Who are some of Alector's key competitors?

What other stocks do shareholders of Alector own?

Who are Alector's key executives?

Alector's management team includes the folowing people:
  • Dr. Tillman U. Gerngross, Co-Founder & Chairman (Age 55)
  • Dr. Arnon Rosenthal, Co-Founder, CEO, Pres & Director (Age 64)
  • Dr. Robert Paul M.D., Ph.D., Chief Medical Officer (Age 51)
  • Dr. Robert S. King, Chief Devel. Officer (Age 56)
  • Dr. Asa Abeliovich M.D., Ph.D., Co-Founder

When did Alector IPO?

(ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

How do I buy shares of Alector?

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Alector's stock price today?

One share of ALEC stock can currently be purchased for approximately $16.00.

How big of a company is Alector?

Alector has a market capitalization of $1.10 billion and generates $27.51 million in revenue each year. The company earns $-52,250,000.00 in net income (profit) each year or ($4.62) on an earnings per share basis. Alector employs 91 workers across the globe.View Additional Information About Alector.

What is Alector's official website?

The official website for Alector is http://www.alector.com/.

How can I contact Alector?

Alector's mailing address is 151 OYSTER POINT BLVD. SUITE 300, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]


MarketBeat Community Rating for Alector (NASDAQ ALEC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  77 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about Alector and other stocks. Vote "Outperform" if you believe ALEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel